| 1 | 10:00-10:20 | 专题发言 |
TBD |
|
||||
| 2 | 10:24-10:44 | 专题发言 |
Comprehensive management of high risk cutaneous SCC |
|
||||
| 3 | 10:48-11:08 | 专题发言 |
TBD |
|
||||
| 4 | 11:12-11:32 | 专题发言 |
TBD |
|
||||
| 5 | 11:36-11:56 | 专题发言 |
Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis and Management Controversies |
|
||||
| 1 | 14:00-14:20 | 专题发言 |
TBD |
|
||||
| 2 | 14:24-14:44 | 专题发言 |
TLR7 genetic modifications in SLE patients |
|
||||
| 3 | 14:48-15:08 | 专题发言 |
Disease Spectrum and Immunological Profile of Generalized Pustular Psoriasis |
|
||||
| 4 | 15:12-15:32 | 专题发言 |
Cutaneous Clues for the Diagnosis of Autoinflammatory Diseases in Infants |
|
||||
| 5 | 15:36-15:56 | 专题发言 |
TBD |
|
||||
| 1 | 16:00-16:20 | 专题发言 |
TBD |
|
||||
| 2 | 16:24-16:44 | 专题发言 |
Factors that influence susceptibility to drug hypersensitivity reactions |
|
||||
| 3 | 16:48-17:08 | 专题发言 |
Update on Hairloss |
|
||||
| 4 | 17:12-17:32 | 专题发言 |
TBD |
|
||||
| 5 | 17:36-17:56 | 专题发言 |
TBD |
|
||||